Multidrug-Resistant Tuberculosis and Beyond: An Updated Analysis of the Current Evidence on Bedaquiline

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.00146-2017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Bedaquiline and Multidrug-Resistant Tuberculosis: A Systematic and Critical Analysis of the Evidence

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science
2019English

New Drugs to Treat Multidrug-Resistant Tuberculosis: The Case for Bedaquiline

Therapeutics and Clinical Risk Management
2014English

Is Bedaquiline as Effective as Fluoroquinolones in the Treatment of Multidrug-Resistant Tuberculosis?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Multidrug and Extensively Drug-Resistant Tuberculosis

Infectious Disease Clinics of North America
Infectious DiseasesMicrobiology
2019English

Classification of Drugs to Treat Multidrug-Resistant Tuberculosis (MDR-TB): Evidence and Perspectives

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Trends in Multidrug-Resistant Tuberculosis

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2008English

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection With Multidrug-Resistant Enterobacteriaceae

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy